Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kara Sevola"'
Autor:
Rianna Vandergaast, Timothy Carey, Samantha Reiter, Chase Lathrum, Patrycja Lech, Clement Gnanadurai, Michelle Haselton, Jason Buehler, Riya Narjari, Luke Schnebeck, Anne Roesler, Kara Sevola, Lukkana Suksanpaisan, Alice Bexon, Shruthi Naik, Bethany Brunton, Scott C. Weaver, Grace Rafael, Sheryl Tran, Alina Baum, Christos A. Kyratsous, Kah Whye Peng, Stephen J. Russell
Publikováno v:
mSphere, Vol 6, Iss 3 (2021)
Since its emergence at the end of 2019, SARS-CoV-2, the causative agent of COVID-19, has caused over 100 million infections and 2.4 million deaths worldwide. Recently, countries have begun administering approved COVID-19 vaccines, which elicit strong
Externí odkaz:
https://doaj.org/article/fd6c7795e5dc4c6292e6a1ae0c6f3949
Autor:
Timothy Carey, Sabarinathan Ramachandran, Lukkana Suksanpaisan, Samantha Reiter, Rachael M Z Lee, Chase Lathrum, Riya Narjari, Rianna Vandergaast, Alina Baum, Christopher D. Petro, Miguel Ángel Muñoz-Alía, Stephen J. Russell, Michelle Haselton, Christos A. Kyratsous, Patrcyja Lech, Lianwen Zhang, Melanie L. Graham, Jody L. Janecek, Karina Krotova, Clement W. Gnanadurai, Mulu Z. Tesfay, Nandakumar Packiriswamy, Toshie Sakuma, Kah Whye Peng, Kara Sevola, Jordan Recker, Luke Russell, Baskar Balakrishnan, Scott Waniger, Christopher Ziegler
Publikováno v:
Vaccine
An orally active vaccine capable of boosting SARS-CoV-2 immune responses in previously infected or vaccinated individuals would help efforts to achieve and sustain herd immunity. Unlike mRNA-loaded lipid nanoparticles and recombinant replication-defe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30be7219bf4507452322215cec68bc3a
https://doi.org/10.1101/2021.10.16.464660
https://doi.org/10.1101/2021.10.16.464660
Autor:
Bethany Brunton, Rianna Vandergaast, Christos A. Kyratsous, Shruthi Naik, Grace H. Rafael, Riya Narjari, Sheryl Tran, Michelle Haselton, Scott C. Weaver, Lukkana Suksanpaisan, Anne Roesler, Alice Bexon, Kah Whye Peng, Kara Sevola, Samantha Reiter, Luke Schnebeck, Clement W. Gnanadurai, Patrycja J. Lech, Alina Baum, Stephen J. Russell, Timothy S. Carey, Chase Lathrum, Jason Buehler
Publikováno v:
mSphere, Vol 6, Iss 3 (2021)
Neutralizing antibodies are key determinants of protection from future infection, yet well-validated high-throughput assays for measuring titers of SARS-CoV-2-neutralizing antibodies are not generally available. Here, we describe the development and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea3c398d1af6cb1e50df577b958d24
https://doi.org/10.1101/2021.02.16.21251653
https://doi.org/10.1101/2021.02.16.21251653